Genetic/JJ
Variants/NNS
of/IN
IL-13/NN
and/CC
IL-4/NN
in/IN
the/DT
Korean/JJ
Population/NN
:/:
Polymorphisms/NNS
,/,
Haplotypes/NNS
and/CC
Linkage/JJ
Disequilibrium/NN
./.
====================
Asthma/NN
is/VBZ
an/DT
inflammatory/JJ
airways/NNS
disease/NN
characterized/VBN
====================
by/IN
bronchial/JJ
hyperresponsiveness/NN
and/CC
airways/NNS
obstruction/NN
,/,
which/WDT
results/VBZ
from/IN
a/DT
complex/NN
interaction/NN
of/IN
genetic/JJ
and/CC
environmental/JJ
factors/NNS
./.
====================
Interleukin/NN
(/(
IL/NN
)/)
-13/CD
and/CC
IL-4/NN
are/VBP
important/JJ
in/IN
IgE/NN
synthesis/NN
and/CC
allergic/JJ
inflammation/NN
,/,
therefore/RB
genes/NNS
encoding/VBG
1L-13/NN
and/CC
IL-4/NN
are/VBP
candidates/NNS
for/IN
predisposition/NN
to/TO
asthma/NN
./.
====================
In/IN
the/DT
present/JJ
study/NN
,/,
we/PRP
screened/VBD
single-nucleotide/JJ
polymorphisms/NNS
(/(
SNPs/NNS
)/)
in/IN
IL-13/NN
and/CC
IL-4/NN
and/CC
examined/VBN
whether/IN
they/PRP
are/VBP
risk/NN
factors/NNS
for/IN
asthma/NN
./.
====================
We/PRP
resequenced/VBD
all/DT
exons/NNS
and/CC
the/DT
promoter/NN
region/NN
in/IN
12/CD
asthma/NN
patients/NNS
and/CC
12/CD
normal/JJ
controls/NNS
,/,
and/CC
identified/VBD
18/CD
SNPs/NNS
including/VBG
2/CD
novel/JJ
SNPs/NNS
./.
====================
The/DT
linkage/NN
disequilibrium/NN
(/(
LD/NN
)/)
pattern/NN
was/VBD
evaluated/VBN
with/IN
16/CD
common/JJ
SNPs/NNS
,/,
and/CC
haplotypes/NNS
were/VBD
also/RB
estimated/VBN
within/IN
the/DT
block/NN
./.
====================
Although/IN
IL-13/NN
and/CC
IL-4/NN
are/VBP
localized/VBN
within/IN
27/CD
kb/NN
on/IN
chromosome/NN
5q31/NN
and/CC
share/VBP
many/JJ
biological/JJ
profiles/NNS
,/,
this/DT
region/NN
was/VBD
partitioned/VBN
into/IN
2/CD
blocks/VBZ
./.
====================
One/CD
SNP/NN
and/CC
three/CD
SNPs/NNS
were/VBD
determined/VBN
as/IN
haplotype-taggingSNPs/NNS
(/(
htSNPs/NNS
)/)
within/IN
IL-13/NN
and/CC
IL-4/NN
haplotype-block/VBP
,/,
respectively/RB
./.
====================
No/DT
significant/JJ
associations/NNS
were/VBD
observed/VBN
between/IN
any/DT
of/IN
the/DT
SNPs/NNS
or/CC
haplotypes/NNS
and/CC
development/NN
of/IN
asthma/NN
in/IN
small/JJ
number/NN
of/IN
Korean/JJ
subjects/NNS
./.
====================
However/RB
,/,
the/DT
genetic/JJ
variants/NNS
of/IN
IL-13/NN
and/CC
IL-4/NN
would/MD
provide/VB
valuable/JJ
strategies/NNS
for/IN
the/DT
genotyping/VBG
studies/NNS
in/IN
large/JJ
population/NN
./.
====================
Asthma/NN
is/VBZ
a/DT
common/JJ
respiratory/JJ
disease/NN
characterized/VBN
by/IN
intermittent/JJ
airways/NNS
obstruction/NN
and/CC
respiratory/JJ
symptoms/NNS
that/DT
are/VBP
caused/VBN
by/IN
acute/JJ
and/CC
chronic/JJ
bronchial/JJ
inflammation/NN
(/(
Renauld/NNP
,/,
2001/CD
)/)
./.
====================
The/DT
development/NN
of/IN
asthma/NN
appears/VBZ
to/TO
be/VB
determined/VBN
by/IN
the/DT
interaction/NN
between/IN
host/NN
susceptibility/NN
and/CC
a/DT
variety/NN
of/IN
environmental/JJ
exposures/NNS
(/(
Howard/RB
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
Linkage/JJ
studies/NNS
have/VBP
mapped/VBN
asthma/NN
susceptibility/NN
genes/NNS
to/TO
a/DT
region/NN
on/IN
chromosome/NN
5q31/NN
containing/VBG
a/DT
cluster/NN
of/IN
proinflammatory/JJ
cytokines/NNS
,/,
including/VBG
interleukin/NN
(/(
IL/NN
)/)
-4/CD
and/CC
IL-13/NN
(/(
Howard/RB
et/FW
al./FW
,/,
2001/CD
;/:
Mansur/NNP
et/FW
al./FW
,/,
1998/CD
)/)
./.
====================
The/DT
IL-13/NN
gene/NN
is/VBZ
located/JJ
12/CD
kb/NN
upstream/RB
of/IN
the/DT
IL-4/NN
gene/NN
in/IN
a/DT
tail-to-head/JJ
orientation/NN
./.
====================
Both/DT
genes/NNS
have/VBP
been/VBN
genetically/RB
and/CC
functionally/RB
implicated/VBN
in/IN
the/DT
pathogenesis/NN
of/IN
asthma/NN
(/(
Heinzmann/JJ
et/FW
al./FW
,/,
2000/CD
;/:
Noguchi/NNP
et/FW
al./FW
,/,
2001/CD
;/:
Walley/NNP
and/CC
Cookson/NN
,/,
1996/CD
)/)
./.
====================
These/DT
CD4/NN
+/JJ
T-helper/NN
type/NN
2/CD
cytokines/NNS
play/VBP
crucial/JJ
role/NN
in/IN
the/DT
allergic/JJ
response/NN
by/IN
regulating/VBG
the/DT
isotype/NN
switch/NN
of/IN
B/NN
cells/NNS
from/IN
IgM/NN
to/TO
IgE/NN
synthesis/NN
(/(
Punnonen/NNP
eta/NN
!/CD
./.
,/,
1994/CD
)/)
./.
====================
They/PRP
appear/VBP
to/TO
share/VB
many/JJ
,/,
but/CC
not/RB
all/DT
,/,
biological/JJ
profiles/NNS
,/,
including/VBG
IgE/NN
production/NN
,/,
CD23/NN
and/CC
MHC/NN
class/NN
II/CD
expression/NN
,/,
inhibition/NN
of/IN
antibody-dependent/JJ
cell/NN
mediated/JJ
cytotoxicity/NN
with/IN
downregulation/NN
of/IN
IgG/NN
receptor/NN
1/CD
(/(
FC7RI/NN
)/)
,/,
and/CC
suppression/NN
of/IN
type/NN
I/CD
interferon/NN
(/(
Izuhara/NN
and/CC
Shirakawa/NN
,/,
1999/CD
;/:
Shirakawa/NN
et/FW
al./FW
,/,
2000/CD
)/)
./.
====================
Although/IN
it/PRP
has/VBZ
been/VBN
previously/RB
demonstrated/VBD
that/IN
genetic/JJ
variants/NNS
of/IN
IL-13/NN
and/CC
IL-4/NN
are/VBP
associated/VBN
with/IN
asthma/NN
or/CC
allergic/JJ
disorders/NNS
in/IN
some/DT
ethnic/JJ
groups/NNS
(/(
Heinzmann/NNP
et/FW
al./FW
,/,
2000/CD
)/)
,/,
real/JJ
association/NN
with/IN
asthma/NN
in/IN
other/JJ
population/NN
still/RB
remains/VBZ
to/TO
be/VB
elucidated/VBN
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
screened/VBD
genetic/JJ
variants/NNS
in/IN
IL-13/NN
and/CC
IL-4/NN
,/,
and/CC
examined/VBN
their/PRP$
associations/NNS
with/IN
development/NN
of/IN
asthma/NN
in/IN
the/DT
small/JJ
number/NN
of/IN
Korean/JJ
subjects/NNS
./.
====================
A/DT
total/JJ
of/IN
24/CD
unrelated/JJ
Korean/JJ
individuals/NNS
consisting/VBG
of/IN
12/CD
asthma/NN
patients/NNS
and/CC
12/CD
normal/JJ
controls/NNS
were/VBD
used/VBN
for/IN
SNP/NN
screening/NN
./.
====================
All/DT
patients/NNS
with/IN
asthma/NN
had/VBD
currently/RB
one/CD
or/CC
more/RBR
asthma/NN
symptoms/NNS
and/CC
the/DT
physical/JJ
examination/NN
compatible/JJ
with/IN
asthma/NN
definition/NN
by/IN
the/DT
====================
American/NN
Thoracic/JJ
Society/NN
(/(
1987/CD
)/)
./.
====================
All/DT
studies/NNS
were/VBD
approved/VBN
by/IN
the/DT
institutional/JJ
review/NN
board/JJ
of/IN
Korea/NN
====================
National/JJ
Institute/JJ
of/IN
Health/NN
,/,
and/CC
written/CD
informed/VBN
consent/NN
was/VBD
obtained/VBN
from/IN
all/DT
participants/NNS
./.
====================
To/TO
identify/VB
common/JJ
single/JJ
nucleotide/NN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
in/IN
IL-13/NN
and/CC
IL-4/NN
,/,
we/PRP
resequenced/VBD
the/DT
entire/JJ
coding/VBG
regions/NNS
and/CC
approximately/RB
up/IN
to/TO
the/DT
~0.5/CD
kb/NN
proximal/JJ
promoter/NN
regions/NNS
in/IN
genomic/JJ
DNA/NN
from/IN
24/CD
selected/VBN
subjects/NNS
./.
====================
The/DT
each/DT
fragment/NN
amplified/VBD
by/IN
PCR/NN
from/IN
genomic/JJ
DNA/NN
was/VBD
sequenced/VBN
on/IN
both/DT
strands/NNS
with/IN
an/DT
ABI/NN
Prism/NN
3100/CD
sequencer/NN
(/(
Applied/VBN
Biosystems/NNS
,/,
Foster/NN
City/NN
,/,
CA/NNP
,/,
USA/NNP
)/)
according/VBG
to/TO
the/DT
manufacturer/NN
's/POS
instructions/NNS
./.
====================
PolyPhred/VBN
program/NN
(/(
http/NN
:/:
//droog.gs.washington/JJ
./.
====================
edu/PolyPhred.html/NN
)/)
was/VBD
used/VBN
to/TO
assemble/JJ
the/DT
sequences/NNS
and/CC
identify/VBP
SNPs/NNS
(/(
Nickerson/NN
etal./FW
,/,
1997/CD
)/)
./.
====================
In/IN
addition/NN
to/TO
resequencing/VBG
,/,
we/PRP
also/RB
selected/VBN
10/CD
known/VBN
SNPs/NNS
of/IN
each/DT
IL-13/NN
and/CC
IL-4/NN
from/IN
NCBI/NN
dbSNP/NN
database/NN
and/CC
genotyped/VBD
for/IN
the/DT
same/JJ
subjects/NNS
using/VBG
TaqMan/JJ
assay/NN
with/IN
an/DT
ABI/NN
Prism/NN
7900HT/CD
Sequence/NN
Detection/NN
System/NN
(/(
Applied/VBN
Biosystems/NNS
,/,
Foster/NN
City/NN
,/,
CA/NNP
,/,
USA/NNP
)/)
./.
====================
The/DT
ethnic/JJ
comparison/NN
of/IN
allele/NN
frequency/NN
was/VBD
performed/VBN
by/IN
searching/VBG
JSNP/NN
database/NN
(/(
http/NN
:/:
//snp.ims.u-tokyo.ac.jp//JJ
)/)
and/or/CC
dbSNP/NN
(/(
http/NN
:/:
//www/JJ
./.
====================
ncbi/RB
./.
====================
nl/RB
m./NN
ni/NNS
h/NN
.gov/SNP//JJ
)/)
database/NN
./.
====================
Deviation/NN
from/IN
Hardy-Weinberg/JJ
expectancy/NN
was/VBD
examined/VBN
with/IN
x/NN
2/CD
test/NN
./.
====================
Lewontin/NN
's/POS
D/NN
1/CD
was/VBD
used/VBN
to/TO
determine/VB
whether/IN
the/DT
pairs/NNS
of/IN
sites/NNS
were/VBD
in/IN
strong/JJ
linkage/NN
disequilibrium/NN
(/(
LD/NN
)/)
./.
====================
Haplotypes/NNS
were/VBD
inferred/VBN
using/VBG
the/DT
PL-EMalgorithm/NN
(/(
http/NN
:/:
//www.people.fas.harvard.edu/-junliu/plen7/CD
)/)
(/(
Qin/NN
et/FW
al./FW
,/,
2002/CD
)/)
./.
====================
Program/NN
SNPtagger/NN
(/(
http/NN
:/:
//www.well/NN
./.
====================
ox.ac.uk//RB
-xiayi/haplotype/index.html/NN
)/)
was/VBD
used/VBN
to/TO
determine/VB
the/DT
haplotype-tagging/JJ
SNPs/NNS
(/(
htSNPs/NNS
)/)
(/(
Ke/NN
and/CC
Cardon/NN
,/,
2003/CD
)/)
./.
====================
The/DT
frequencies/NNS
of/IN
alleles/NNS
,/,
genotypes/NNS
and/CC
haplotypes/NNS
were/VBD
compared/VBN
between/IN
patients/NNS
and/CC
controls/VBZ
by/IN
Fisher/JJ
's/POS
exact/JJ
test/NN
or/CC
\/JJ
2/CD
statistic/JJ
,/,
as/IN
appropriate/JJ
,/,
using/VBG
SAS/NN
for/IN
windows/VBZ
V8/NN
(/(
SAS/NN
institute/JJ
Inc./NNP
,/,
Cary/NN
,/,
NC/NN
,/,
USA/NNP
)/)
./.
====================
Statistical/JJ
significance/NN
was/VBD
inferred/VBN
at/IN
a/DT
two-tailed/JJ
value/NN
of/IN
P/NN
</JJR
0.05/CD
./.
====================
Resequencing/VBG
and/CC
genotyping/VBG
of/IN
IL-13/NN
and/CC
IL-4/NN
genomic/JJ
DNA/NN
in/IN
24/CD
samples/NNS
(/(
including/VBG
12/CD
asthma/NN
patients/NNS
and/CC
12/CD
====================
normal/JJ
controls/NNS
)/)
identified/VBD
18/CD
SNPs/NNS
,/,
including/VBG
2/CD
novel/JJ
SNPs/NNS
,/,
in/IN
the/DT
Korean/JJ
population/NN
(/(
Fig.la/NN
and/CC
Table/JJ
1/CD
)/)
:/:
7/CD
SNPs/NNS
in/IN
IL-13/NN
and/CC
11/CD
SNPs/NNS
in/IN
IL-4/NN
,/,
respectively/RB
./.
====================
As/IN
shown/VBN
in/IN
Table/JJ
1/CD
,/,
there/EX
were/VBD
substantial/JJ
differences/NNS
of/IN
allele/NN
frequencies/NNS
among/IN
different/JJ
ethnic/JJ
groups/NNS
./.
====================
Furthermore/RB
,/,
some/DT
SNPs/NNS
with/IN
allele/NN
frequency/NN
up/IN
to/TO
0.2/CD
in/IN
Africans/NNS
,/,
selected/VBN
from/IN
NCBI/NN
dbSNP/NN
database/NN
,/,
showed/VBD
monomorphic/JJ
genotyping/VBG
data/NNS
in/IN
Koreans/NNS
:/:
rs3212145/JJ
,/,
rs2069746/RB
,/,
rs2069749/NN
and/CC
rs2069750/NN
of/IN
IL-13/NN
;/:
rs2243251/RB
,/,
rs4986964/NN
and/CC
rs2243286/NN
of/IN
IL-4/NN
(/(
data/NNS
not/RB
shown/VBN
)/)
./.
====================
These/DT
results/NNS
reconfirmed/VBD
that/DT
an/DT
extensive/JJ
verification/NN
of/IN
public/JJ
SNPs/NNS
in/IN
a/DT
particular/JJ
population/NN
studied/VBD
should/MD
be/VB
undertaken/VBN
prior/JJ
to/TO
their/PRP$
association/NN
studies/NNS
as/IN
previously/RB
reported/VBD
(/(
Lee/NNP
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
The/DT
result/NN
of/IN
LD/NN
analysis/NN
of/IN
IL-13/NN
and/CC
IL-4/NN
was/VBD
summarized/VBN
in/IN
Fig/NN
./.
====================
1b/NN
./.
====================
Since/IN
ID/NN
'/``
I/NN
are/VBP
strongly/RB
inflated/VBN
for/IN
SNPs/NNS
with/IN
rare/JJ
alleles/NNS
,/,
high/JJ
values/NNS
can/MD
be/VB
obtained/VBN
even/RB
when/WRB
markers/NNS
are/VBP
in/IN
fact/NN
in/IN
linkage/NN
equilibrium/NN
(/(
Ardlie/NN
et/FW
al./FW
,/,
2002/CD
)/)
./.
====================
Therefore/RB
,/,
SNPs/NNS
with/IN
frequency/NN
at/IN
least/JJS
5/CD
%/NN
were/VBD
used/VBN
for/IN
LD/NN
analysis/NN
./.
====================
Even/RB
if/IN
IL-13/NN
and/CC
IL-4/NN
are/VBP
localized/VBN
within/IN
27/CD
kb/NN
on/IN
the/DT
proximal/JJ
portion/NN
of/IN
chromosome/NN
5q31/NN
and/CC
share/VBP
many/JJ
biologic/JJ
activities/NNS
,/,
this/DT
region/NN
was/VBD
decomposed/VBN
into/IN
discrete/JJ
2/CD
haplotype­/NN
blocks/VBZ
in/IN
the/DT
Korean/JJ
population/NN
./.
====================
Complete/JJ
LD/NN
was/VBD
observed/VBN
between/IN
any/DT
2/CD
of/IN
10/CD
SNPs/NNS
in/IN
IL-4/NN
,/,
whereas/IN
there/EX
was/VBD
no/DT
strong/JJ
LD/NN
between/IN
the/DT
+571/CD
C/NN
>/JJR
A/DT
and/CC
the/DT
others/NNS
in/IN
IL-13/NN
./.
====================
From/IN
this/DT
result/NN
,/,
we/PRP
could/MD
deduce/VB
that/DT
there/EX
might/MD
be/VB
more/RBR
than/IN
one/CD
haplotype-block/NN
in/IN
IL-13/NN
./.
====================
Halotypes/NNS
were/VBD
constructed/VBN
on/IN
the/DT
basis/NN
of/IN
the/DT
genotype/NN
data/NNS
using/VBG
PL-EM/NN
algorithm/NN
within/IN
each/DT
block/VBP
./.
====================
Two/CD
haplotypes/NNS
,/,
identified/VBD
in/IN
IL-13/NN
,/,
accounted/VBN
for/IN
all/DT
observed/VBN
haplotype/NN
diversity/NN
(/(
Fig/NN
./.
====================
1b/NN
)/)
./.
====================
Any/DT
one/CD
of/IN
5/CD
SNPs/NNS
within/IN
the/DT
IL-13/NN
haplotype-block/VBP
was/VBD
determined/VBN
as/IN
htSNP/NN
,/,
because/IN
they/PRP
were/VBD
completely/RB
matched/VBN
./.
====================
In/IN
IL-4/NN
,/,
four/CD
haplotypes/NNS
were/VBD
identified/VBN
,/,
and/CC
2/CD
dominant/JJ
haplotypes/NNS
with/IN
frequencies/NNS
over/IN
5/CD
%/NN
accounted/VBN
for/IN
96/CD
%/NN
of/IN
all/DT
haplotypes/NNS
(/(
Fig/NN
./.
====================
1/CD
b/NN
)/)
./.
====================
There/EX
were/VBD
3/CD
htSNPs/NNS
,/,
which/WDT
capture/RB
100/CD
%/NN
of/IN
the/DT
haplotype/JJ
diversity/NN
observed/VBN
within/IN
IL-4/NN
,/,
as/IN
follows/VBZ
:/:
htSNPI/RB
was/VBD
any/DT
one/CD
of/IN
-219/CD
T/NN
>/JJR
C/NN
,/,
+338/CD
T/NN
>/JJR
C/NN
,/,
+1354/CD
T/NN
>/JJR
C/NN
,/,
+4417/CD
A/DT
>/JJR
G/NN
,/,
+4591/CD
C/NN
>/JJR
A/DT
and/CC
+5460/CD
A/DT
>/JJR
G/NN
;/:
htSNP2/RB
was/VBD
any/DT
one/CD
of/IN
+8572G/JJ
>/JJR
A/DT
,/,
+8760/CD
G/NN
>/JJR
A/DT
and/CC
+8797/CD
A/DT
>/JJR
C/NN
;/:
htSNP3/RB
was/VBD
+3353/CD
T/NN
>/JJR
G/NN
./.
====================
In/IN
case/NN
of/IN
covering/VBG
2/CD
common/JJ
haplotypes/NNS
,/,
any/DT
one/CD
of/IN
10/CD
SNPs/NNS
was/VBD
identified/VBN
as/IN
htSNP/NN
within/IN
IL-4/NN
./.
====================
For/IN
each/DT
SNP/NN
,/,
the/DT
genotype/NN
frequency/NN
was/VBD
consistent/JJ
with/IN
Hardy-Weinberg/JJ
equilibrium/NN
(/(
P/NN
>/JJR
0.31/CD
)/)
and/CC
those/DT
of/IN
three/CD
alternative/JJ
models/NNS
,/,
such/JJ
as/IN
,/,
co-dominant/JJ
,/,
dominant/JJ
and/CC
recessive/JJ
models/NNS
,/,
were/VBD
not/RB
significantly/RB
different/JJ
between/IN
patients/NNS
and/CC
controls/VBZ
(/(
P/NN
>/JJR
0.59/CD
)/)
(/(
data/NNS
not/RB
====================
shown/VBN
)/)
./.
====================
No/DT
significant/JJ
differences/NNS
in/IN
allele/NN
frequencies/NNS
were/VBD
also/RB
observed/VBN
between/IN
two/CD
groups/NNS
(/(
data/NNS
not/RB
shown/VBN
)/)
./.
====================
We/PRP
further/RB
performed/VBN
association/NN
analyses/NNS
between/IN
the/DT
haplotypes/NNS
with/IN
frequency/NN
more/RBR
than/IN
5/CD
%/NN
and/CC
development/NN
of/IN
asthma/NN
./.
====================
However/RB
,/,
no/DT
statistically/RB
significant/JJ
associations/NNS
were/VBD
observed/VBN
(/(
P/NN
>/JJR
0.64/CD
)/)
(/(
data/NNS
not/RB
shown/VBN
)/)
./.
====================
Although/IN
there/EX
were/VBD
no/DT
significant/JJ
associations/NNS
between/IN
all/DT
single/JJ
SNPs/NNS
or/CC
common/JJ
haplotypes/NNS
and/CC
development/NN
of/IN
asthma/NN
,/,
further/RB
studies/NNS
would/MD
be/VB
needed/VBN
to/TO
examine/VB
whether/IN
their/PRP$
association/NN
with/IN
asthma/NN
using/VBG
a/DT
large/JJ
disease/NN
samples/NNS
with/IN
well-defined/JJ
asthmatic/JJ
phenotypes/NNS
such/JJ
as/IN
serum/NN
IgE/NN
level/NN
./.
====================
Our/PRP$
results/NNS
will/MD
be/VB
useful/JJ
to/TO
select/VB
an/DT
optimal/JJ
reference/NN
set/NN
of/IN
SNPs/NNS
for/IN
any/DT
subsequent/JJ
genotyping/VBG
study/NN
in/IN
large/JJ
population/NN
./.
====================
